FAMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Farmmi Inc (FAMI) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is in a clear bearish trend, has just suffered a major selloff from a public offering, and there is no strong proprietary buy signal to offset the weakness. Given the user is impatient and does not want to wait for an ideal entry, the direct call is to avoid buying and stay out.
FAMI shows a strongly bearish technical setup. The MACD histogram is -0.116 and expanding negatively, confirming downward momentum. RSI_6 is 15.277, which is deeply oversold, but in this case oversold does not outweigh the broader trend because the moving averages are still bearish with SMA_200 > SMA_20 > SMA_5. Price at 0.1971 is far below the reported pivot (0.849) and even below S1 (0.324), showing the stock is trading in a very weak zone. The recent stock trend projection also suggests negative performance over the next week and month. Overall, the trend is down and there is no sign of reversal strength.
The only near-term supportive factor is that the stock is extremely oversold, which can sometimes lead to a short technical bounce. The company also completed a public offering, which may improve short-term liquidity and keep operations funded.
The biggest negative catalyst is the recent underwritten public offering of 12 million shares at $0.25, which triggered a massive price collapse and signals dilution pressure. The news flow is dominated by capital raising rather than growth or business momentum. Technical momentum is weak, hedge funds and insiders are neutral, there is no AI Stock Picker or SwingMax signal, and the modeled trend remains negative over the next week and month.
Financial snapshot data is unavailable due to an error, so there is no usable latest-quarter financial breakdown to assess growth trends. Based on the available news, the latest quarter context is not supportive from a market-performance standpoint because the company is raising capital rather than demonstrating strong operating growth.
No analyst rating or price target change data was provided, so there is no evidence of improving Wall Street sentiment. From the available information, the Wall Street pros view is weak: there are no bullish revisions, no rising targets, and no supportive institutional or insider accumulation signals. The cons view dominates because the stock has severe dilution pressure, poor momentum, and no confirmed catalyst-driven upgrade cycle. Recent rating/target trend: unavailable.
